BioMarin to Present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, at 9:00 am PT / 12:00 pm ET, in San Francisco, CA

BioMarin Pharmaceutical (NASDAQ: BMRN) has announced its participation in the 43rd Annual J.P.

Rhea-AI Summary

BioMarin Pharmaceutical (NASDAQ: BMRN) has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, California. Alexander Hardy, the company's President and Chief Executive Officer, will deliver a presentation on Monday, January 13, 2024, at 9:00 am PT / 12:00 pm ET.

The presentation will be accessible through a live audio webcast on the company's investor relations website. For those unable to attend or watch live, an archived version of the presentation will be available for a time through BioMarin's website.

Argus Session date unavailable

+0.36% session move Open Argus

Details

News Market Reaction – BMRN

The recorded move for BMRN in the trading session of this news was +0.36%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SAN RAFAEL, Calif., Jan. 6, 2025 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Alexander Hardy, President and Chief Executive Officer of BioMarin, will present at the 43rd Annual J.P. Morgan Conference on Monday, January 13, 2024, at 9:00 am PT / 12:00 pm ET, in San Francisco, California.

An audio webcast of the presentation will be available live. You can access the webcast at: https://investors.biomarin.com/. An archived version of the remarks will also be available through the Company's website for a limited time following the conference. 

About BioMarin
BioMarin is a global biotechnology company dedicated to translating the promise of genetic discovery into medicines that make a profound impact on the life of each patient. The San Rafael, California-based company, founded in 1997, has a proven track record of innovation with eight commercial therapies and a strong clinical and preclinical pipeline. Using a distinctive approach to drug discovery and development, BioMarin pursues treatments that offer new possibilities for patients and families around the world navigating rare or difficult-to-treat genetic conditions. To learn more, please visit www.biomarin.com.   

Contacts:
Investors	Media
Traci McCarty	Marni Kottle
BioMarin Pharmaceutical Inc.	BioMarin Pharmaceutical Inc.
(415) 455-7558	(650) 374-2803

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/biomarin-to-present-at-the-43rd-annual-jp-morgan-healthcare-conference-on-monday-january-13-at-900-am-pt--1200-pm-et-in-san-francisco-ca-302342007.html

SOURCE BioMarin Pharmaceutical Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is BioMarin (BMRN) presenting at the 2024 J.P. Morgan Healthcare Conference?

BioMarin (BMRN) is presenting on Monday, January 13, 2024, at 9:00 am PT / 12:00 pm ET in San Francisco, California.

How can investors watch BioMarin's (BMRN) J.P. Morgan Healthcare Conference presentation?

Investors can watch the presentation through a live audio webcast available at BioMarin's investor relations website: https://investors.biomarin.com/

Who will be presenting for BioMarin (BMRN) at the 2024 J.P. Morgan Healthcare Conference?

Alexander Hardy, BioMarin's President and Chief Executive Officer, will be presenting at the conference.

Will BioMarin's (BMRN) J.P. Morgan Healthcare Conference presentation be available after the event?

Yes, an archived version of the presentation will be available through BioMarin's website for a time following the conference.